Results for Tumor Necrosis Factor (TNF) Alpha Inhibitor

A combination of aerobic exercise and resistance training was effective in reducing inflammation.

Article Published Date : Mar 01, 2017
Study Type : Human Study
Additional Links
Diseases : Inflammation : CK(16094) : AC(5496), Postmenopausal Complications
Therapeutic Actions : Exercise: Aerobic : CK(1150) : AC(150), Exercise: Resistance Training : CK(1006) : AC(116)
Pharmacological Actions : Anti-Inflammatory Agents : CK(39737) : AC(15858), Tumor Necrosis Factor (TNF) Alpha Inhibitor : CK(11697) : AC(4806)
Additional Keywords : Anti-Inflammatory Agents, Exercise: Aerobic, Exercise: Resistance Training, Inflammation : CK(128) : AC(57), Postmenopausal Complications : CK(30) : AC(2), Tumor Necrosis Factor (TNF) Alpha Inhibitor

Baicalein could be a lead compound for the modulation of inflammatory diseases as well as certain cancers.

Article Published Date : Oct 31, 2016
Study Type : In Vitro Study
Additional Links
Substances : Baicalein : CK(312) : AC(202)
Diseases : Cervical Cancer : CK(975) : AC(595), Inflammation : CK(16094) : AC(5496)
Pharmacological Actions : Anti-Inflammatory Agents : CK(39737) : AC(15858), NF-kappaB Inhibitor : CK(5952) : AC(3464), Tumor Necrosis Factor (TNF) Alpha Inhibitor : CK(11697) : AC(4806)
Additional Keywords : Anti-Inflammatory Agents, Baicalein, Cervical Cancer, Gene Expression Regulation : CK(1401) : AC(623), NF-kappaB Inhibitor, Tumor Necrosis Factor (TNF) Alpha Inhibitor

Docosahexaenoic acid might influence the process of oligodendrocyte progenitor maturation.

Article Published Date : Jun 20, 2017
Study Type : In Vitro Study
Additional Links
Substances : DHA (Docosahexaenoic Acid) : CK(1285) : AC(244)
Diseases : Demyelinating Diseases : CK(3227) : AC(780), Multiple Sclerosis : CK(2432) : AC(557)
Pharmacological Actions : Tumor Necrosis Factor (TNF) Alpha Inhibitor : CK(11697) : AC(4806)
Additional Keywords : Demyelinating Diseases, DHA (Docosahexaenoic Acid), Multiple Sclerosis : CK(38) : AC(8), Tumor Necrosis Factor (TNF) Alpha Inhibitor

Lactobacillus plantarum alleviates aflatoxins B1 and M1 induced disturbances in the intestinal genes expression and DNA fragmentation.

Article Published Date : Mar 20, 2018
Study Type : Animal Study
Additional Links
Substances : Lactobacillus plantarum : CK(1008) : AC(308)
Diseases : DNA damage : CK(2301) : AC(842)
Pharmacological Actions : Genoprotective : CK(522) : AC(203), Tumor Necrosis Factor (TNF) Alpha Inhibitor : CK(11697) : AC(4806)
Additional Keywords : DNA damage, Gene Expression Regulation : CK(1401) : AC(623), Genoprotective, Lactobacillus plantarum, Tumor Necrosis Factor (TNF) Alpha Inhibitor
Problem Substances : Aflatoxin : CK(230) : AC(87)

Lycopene has a protective effect on non-alcoholic fatty liver disease.

Article Published Date : Dec 13, 2016
Study Type : Animal Study
Additional Links
Substances : Lycopene : CK(1267) : AC(372)
Diseases : Nonalcoholic fatty liver disease (NAFLD) : CK(3451) : AC(969)
Pharmacological Actions : Antioxidants : CK(34551) : AC(14499), Hepatoprotective : CK(8989) : AC(3831), Tumor Necrosis Factor (TNF) Alpha Inhibitor : CK(11697) : AC(4806)
Additional Keywords : Antioxidants : CK(303) : AC(126), Dose Response : CK(1770) : AC(700), Hepatoprotective, lycopene, Nonalcoholic fatty liver disease (NAFLD), Tumor Necrosis Factor (TNF) Alpha Inhibitor

Puerarin prevents LPS-induced acute lung injury via inhibiting inflammatory response.

Article Published Date : Mar 19, 2018
Study Type : In Vitro Study
Additional Links
Substances : Puerarin : CK(777) : AC(388)
Diseases : Lipopolysaccharide-Induced Toxicity : CK(3229) : AC(1875), Lung Injury: Acute : CK(533) : AC(253)
Pharmacological Actions : Anti-Inflammatory Agents : CK(39737) : AC(15858), Tumor Necrosis Factor (TNF) Alpha Inhibitor : CK(11697) : AC(4806)
Additional Keywords : Anti-Inflammatory Agents, Lipopolysaccharide-Induced Toxicity, Lung Injury: Acute, Puerarin, Tumor Necrosis Factor (TNF) Alpha Inhibitor

Puerarin treatment may represent a novel approach to lowering the risk of or improving function in ischemia-reperfusion brain injury-related disorders.

Article Published Date : Jan 18, 2009
Study Type : Animal Study
Additional Links
Substances : Puerarin : CK(777) : AC(388)
Diseases : Brain Ischemia : CK(582) : AC(255), Middle Cerebral Artery Occlusion (MCAO) : CK(121) : AC(53)
Pharmacological Actions : Antioxidants : CK(34551) : AC(14499), Neuroprotective Agents : CK(20061) : AC(7949), Tumor Necrosis Factor (TNF) Alpha Inhibitor : CK(11697) : AC(4806), Vasodilator Agents : CK(892) : AC(233)
Additional Keywords : Antioxidants : CK(303) : AC(126), Brain Ischemia, Middle Cerebral Artery Occlusion (MCAO), Neuroprotective Agents, Tumor Necrosis Factor (TNF) Alpha Inhibitor, Vasodilator Agents

Connect with GreenMedInfo